BioAmber clinches Lanxess funding, partners with NatureWorks to form AmberWorks

BioAmber closed a Series C funding round for $30 million, with Lanxess participating in the latter of two tranches with $10 million and joining the BioAmber board. Existing investors Naxos Capital, Sofinnova Partners, Mitsui, and the Cliffton Group contributed a total of $20 million in November 2011...

This item has been archived in line with our efforts to keep our content relevant and up to date for our readership. For further assistance, please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

Spinnova adds yet another brand name to its list of partners – this time, it's The North Face

News Commentary | August 25, 2021

Spinnova previously announced partnership deals with major brands including H&M and Adidas, and now it has added The North Face to its impressive downstream partner list. Fashion and outdoor brands including The North Face have made commitments to switch to more sustainable materials. In this ... Not part of subscription

Mitsubishi takes shot at being first to commercialize MMA from biobased feedstock

News Commentary | February 25, 2022

The global demand for MMA (methyl methacrylate) exceeded 6.8 million tonnes in 2020. But MMA producers have been slow to adopt biobased feedstocks, as they've done with precursors for more common plastics like polyethylene and polypropylene. Mitsubishi Chemical Corporation and its subsidiary ... Not part of subscription

Round two: Avantium begins construction of its FDCA flagship plant after its long-awaited financial close

News Commentary | April 21, 2022

After years of uncertainties and a huge falling out with Synvina and BASF, Avantium has finally secured the funding it needs to build its FDCA (furandicarboxylic acid) flagship plant. The company has received EUR 90 million in debt financing from a consortium of Dutch banks for the financial close. ... Not part of subscription